Reference Curves for Bone Mineral Density and Body Composition in Women Aged 20-89

ConditionBone Density
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age20-89
SponsorCentre Hospitalier Universitaire de Nīmes

About this trial

Up-to-date normalcy curves for bone mineral density and body composition (fat and lean mass), are currently lacking. DMS IMAGING is therefore financing the MONIKA study, with Nîmes University Hospital as sponsor.

Some 425 healthy female volunteers aged 20 to 89 will be recruited from three centers (Nîmes, Montpellier and Lyon). A bone density scan at various bone sites (femur, rachis, radius and whole body) will provide up-to-date normalcy curves for bone mineral density as well as body composition (fat and lean mass). These measurements should help to better understand bone physiology and the links that may exist between bone tissue and muscle and adipose tissue.

This is a prospective multicenter cross-sectional descriptive study of healthy female volunteers. The study population is made up of healthy female volunteers from Europe, the Middle East and North Africa aged between 20 and 89, stratified into 7 age groups.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Ethnic origin European, Middle Eastern, North African and whose 2 parents are from Europe, Middle East, North Africa only as there is a difference in BMD according to ethnicity

Person affiliated to or benefiting from a social security scheme

Free, informed consent signed by the participant and the investigator (on the day of inclusion and before any examination required by the research).

Disqualifiers

Fragility fracture defined as a spontaneous or low-kinetic fracture (≤ one fall from height)

Hip fracture in a first-degree relative

Early menopause (< age 40), Hysterectomy (complete < age 40), Primary amenorrhea (absence of menstruation before age 15), Current amenorrhea of more than 3 months without contraceptive if patient is under age 40

Treatments : Prolonged corticosteroid therapy > 3 months or > 1 g (cumulative dose)

Trial design

Design model

Factorial

Treatments tested in this trial

  • Bone densitometry scan

    Radiation

    Each study participant will undergo a bone density measurement scan. The equipment used in this study will be the STRATOS DR X-ray bone densitometer (APELEM, 9 Avenue du Canal Philippe Lamour, 30660 Gallargues-le-Montueux, France). This device is indicated for diagnosing osteoporosis, assessing the risk of fracture in weakened bone areas, monitoring bone density, monitoring body composition and diagnosing vertebral anomalies (vertebral compression, fractures). In general, the time for a scan is less than 1 min for the spine, less than than 1 min for the femur, less than 1 min for the forearm and around 4 min for the whole body. The total duration of the patient's participation in this research will be approximately 2 hours.

Treatment groups

425 Participants
are divided into 7 treatment groups

7

Treatment groups

See each treatment group below.

Group A: Women aged 20-29Other 1 intervention
Group B: Women aged 30-39Other 1 intervention
Group C: Women aged 40-49Other 1 intervention
Group D: Women aged 50-59Other 1 intervention
Group E: Women aged 60-69Other 1 intervention
Group F: Women aged 70-79Other 1 intervention
Group G: Women aged 80-89Other 1 intervention

Trial outcomes

Primary outcomes

1

Bone mineral density of the femoral neck: Left side

Bone mineral density (BMD in g/cm2) for the construction of Z score and T score

Time frame
Day 0, day of inclusion
2

Bone mineral density of the femoral neck: Right side

Bone mineral density (BMD in g/cm2) for the construction of Z score and T score

Time frame
Day 0, day of inclusion
3

Bone mineral density of the femoral neck: Lumbar spine (L1 - L4)

Bone mineral density (BMD in g/cm2) for the construction of Z score and T score

Time frame
Day 0, day of inclusion
4

Bone mineral density of the femoral neck: Forearm

Bone mineral density (BMD in g/cm2) for the construction of Z score and T score

Time frame
Day 0, day of inclusion

Secondary outcomes

1

Percentage body fat: left hip

Measured automatically by the STRATOS DR X-ray bone densitometer in %

Time frame
Day 0, day of inclusion
2

Body fat: left hip

Measured automatically by the STRATOS DR X-ray bone densitometer in kg

Time frame
Day 0, day of inclusion
3

Percentage body fat: right hip

Measured automatically by the STRATOS DR X-ray bone densitometer in %

Time frame
Day 0, day of inclusion
4

Body fat: right hip

Measured automatically by the STRATOS DR X-ray bone densitometer in kg

Time frame
Day 0, day of inclusion

Other outcomes

1

Weight of participants

The weight of each participant will be recorded in kg

Time frame
Day 0, day of inclusion
2

Height of participants

The height of each participant will be recorded in cm

Time frame
Day 0, day of inclusion
3

Body Mass Index of participants

The body mass index (BMI) of each participant will be calculated as follows : BMI = weight \[kg\] / height 2 \[m2\]

Time frame
Day 0, day of inclusion

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Centre Hospitalier Universitaire de Nīmes

Lead sponsor

University Hospital, Montpellier

Collaborator

Hôpital Edouard Herriot

Collaborator

This trial is not recruiting at the moment. You can still explore other options: